Gerner R H, Psarras J, Kirschenbaum M A
Am J Psychiatry. 1980 Jul;137(7):834-7. doi: 10.1176/ajp.137.7.834.
Because there have been reports suggesting that patients who receive lithium are at risk for renal damage, the authors carried out extensive noninvasive testing of renal function in 43 patients who had been taking lithium for from 1 to 120 months. Their only abnormal finding was that the urine concentrating ability of these patients was moderately but asymptomatically impaired. They suggest that although patients receiving lithium should be carefully evaluated and tested, there is not enough evidence to justify not initiating or continuing lithium use in patients who might benefit from it.
因为有报告表明接受锂治疗的患者有肾脏损害风险,作者对43名服用锂1至120个月的患者进行了广泛的肾功能无创检测。他们唯一的异常发现是这些患者的尿液浓缩能力有中度但无症状的损害。他们建议,虽然接受锂治疗的患者应接受仔细评估和检测,但没有足够证据证明不让可能从中受益的患者开始或继续使用锂是合理的。